{
     "PMID": "26480813",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160930",
     "LR": "20170220",
     "IS": "1873-7544 (Electronic) 0306-4522 (Linking)",
     "VI": "313",
     "DP": "2016 Jan 28",
     "TI": "Impact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus.",
     "PG": "46-56",
     "LID": "10.1016/j.neuroscience.2015.10.022 [doi] S0306-4522(15)00929-X [pii]",
     "AB": "Delta opioid (DOP) receptors participate to the control of chronic pain and emotional responses. Recent data also identified their implication in spatial memory and drug-context associations pointing to a critical role of hippocampal delta receptors. To better appreciate the impact of repeated drug exposure on their modulatory activity, we used fluorescent knock-in mice that express a functional delta receptor fused at its carboxy-terminus with the green fluorescent protein in place of the native receptor. We then tested the impact of chronic morphine treatment on the density and distribution of delta receptor-expressing cells in the hippocampus. A decrease in delta receptor-positive cell density was observed in the CA1, CA3 and dentate gyrus without alteration of the distribution across the different GABAergic populations that mainly express delta receptors. This effect partly persisted after four weeks of morphine abstinence. In addition, we observed increased DOP receptor expression at the cell surface compared to saline-treated animals. In the hippocampus, chronic morphine administration thus induces DOP receptor cellular redistribution and durably decreases delta receptor-expressing cell density. Such modifications are likely to alter hippocampal physiology, and to contribute to long-term cognitive deficits.",
     "CI": [
          "Copyright (c) 2015 IBRO. Published by Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Erbs, E",
          "Faget, L",
          "Ceredig, R A",
          "Matifas, A",
          "Vonesch, J-L",
          "Kieffer, B L",
          "Massotte, D"
     ],
     "AU": [
          "Erbs E",
          "Faget L",
          "Ceredig RA",
          "Matifas A",
          "Vonesch JL",
          "Kieffer BL",
          "Massotte D"
     ],
     "AD": "Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France. Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France. Institut des Neurosciences Cellulaires et Integratives, UPR 3212, 5 Rue Blaise Pascal, F-67084 Strasbourg, France. Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France. Imaging Center IGBMC, CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France. Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France; Douglas Hospital Research Center, Department of Psychiatry, McGill University, 6875, Boulevard LaSalle, Montreal (Quebec) H4H 1R3, Canada. Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS/INSERM/UdS, 1 Rue Laurent Fries, F-67404 Illkirch-Graffenstaden, France; Institut des Neurosciences Cellulaires et Integratives, UPR 3212, 5 Rue Blaise Pascal, F-67084 Strasbourg, France. Electronic address: d.massotte@unistra.fr.",
     "LA": [
          "eng"
     ],
     "GR": [
          "P50 DA005010/DA/NIDA NIH HHS/United States",
          "(#DA 005010/DA/NIDA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151019",
     "PL": "United States",
     "TA": "Neuroscience",
     "JT": "Neuroscience",
     "JID": "7605074",
     "RN": [
          "0 (Narcotics)",
          "0 (Receptors, Opioid, delta)",
          "147336-22-9 (Green Fluorescent Proteins)",
          "76I7G6D29C (Morphine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Chronic Disease",
          "Disease Models, Animal",
          "Female",
          "Gene Knock-In Techniques",
          "Green Fluorescent Proteins/genetics/metabolism",
          "Hippocampus/*drug effects/metabolism/pathology",
          "Immunohistochemistry",
          "Male",
          "Mice, 129 Strain",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Morphine/*pharmacology",
          "Morphine Dependence/metabolism/pathology",
          "Narcotics/*pharmacology",
          "Neurons/*drug effects/metabolism/pathology",
          "Receptors, Opioid, delta/genetics/*metabolism"
     ],
     "PMC": "PMC4695264",
     "MID": [
          "NIHMS731406"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "G protein-coupled receptor",
          "abstinence",
          "chronic morphine",
          "delta opioid receptor",
          "hippocampus"
     ],
     "EDAT": "2015/10/21 06:00",
     "MHDA": "2016/10/01 06:00",
     "CRDT": [
          "2015/10/21 06:00"
     ],
     "PHST": [
          "2015/07/27 00:00 [received]",
          "2015/10/08 00:00 [revised]",
          "2015/10/12 00:00 [accepted]",
          "2015/10/21 06:00 [entrez]",
          "2015/10/21 06:00 [pubmed]",
          "2016/10/01 06:00 [medline]"
     ],
     "AID": [
          "S0306-4522(15)00929-X [pii]",
          "10.1016/j.neuroscience.2015.10.022 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuroscience. 2016 Jan 28;313:46-56. doi: 10.1016/j.neuroscience.2015.10.022. Epub 2015 Oct 19.",
     "term": "hippocampus"
}